How to Implement an Opioid Stewardship Checklist in Your Pharmacy

Opioid stewardship gives pharmacy teams a practical way to promote safe, appropriate and person-centred use of opioid medicines. A standardized checklist supports consistent decisions at the point of dispensing, especially when a prescription involves a high-risk medicine, a new patient, a dose escalation or a complicated treatment history.

In Australia, this work sits within a regulated environment shaped by state and territory medicines legislation, Schedule 8 requirements, real-time prescription monitoring and professional standards. A checklist cannot replace clinical judgement or local law. It creates a reliable prompt for the questions, checks and conversations that can otherwise be missed during a busy dispensary shift.

The strongest systems are designed with pharmacists, dispensary technicians, prescribers and patients in mind. They should fit normal workflow rather than operate as a separate paperwork exercise. A well-built tool can improve documentation, identify overdose risk, encourage naloxone access and make escalation to the prescriber more timely.

Opioid stewardship also involves respectful communication. A patient collecting oxycodone after surgery, a person receiving long-term therapy for chronic pain and someone using opioid agonist treatment may have very different needs. The checklist should help staff provide consistent safeguards without creating stigma or assuming misuse.

Define The Purpose And Scope

Begin by writing a short purpose statement for the pharmacy. It might specify that the checklist is used to support safe dispensing, identify clinical risk, improve continuity of care and document interventions involving opioid analgesics or opioid dependence treatment. This statement helps the team understand that stewardship is a patient-safety process, not a surveillance exercise.

The scope should identify which medicines and situations trigger the checklist. Include Schedule 8 opioid analgesics, opioid-containing products where clinically relevant, opioid substitution medicines and prescriptions involving dose changes or unusual directions. Consider automatic prompts for new patients, early supply requests, lost or stolen medicine reports, multiple prescribers, concurrent benzodiazepines and transitions from hospital to community care.

Australian pharmacies should map the process to local requirements. A Victorian pharmacy may use SafeScript, while a Queensland pharmacy may work with QScript; other jurisdictions have their own real-time prescription monitoring arrangements and implementation settings. The checklist should direct the pharmacist to the applicable system without implying that a software record alone resolves the clinical question.

Define who can complete each part. Technicians may prepare administrative information, check identification according to pharmacy policy and flag missing details, while the pharmacist conducts the clinical assessment and makes the final decision. This division protects efficiency while keeping professional judgement with the registered pharmacist.

Build The Clinical Safety Prompts

A useful checklist begins with prescription validation. Confirm the patient’s identity, medicine, strength, formulation, quantity, directions, indication where known, prescriber details and date. Check whether the dose and supply are clinically plausible, whether the formulation is suitable and whether the prescription meets state or territory requirements for Schedule 8 medicines.

The next prompts should cover opioid-related risk. Ask whether the patient is opioid-naive, receiving long-term treatment, recently discharged from hospital or using another opioid source. Review relevant medicines such as benzodiazepines, sedating antipsychotics, gabapentinoids, sedating antihistamines and alcohol use where the patient is comfortable discussing it. Consider respiratory disease, sleep apnoea, renal or hepatic impairment, pregnancy and a history of overdose or substance dependence.

Monitoring systems can reveal useful information, but they require interpretation. A patient may see several prescribers because of a genuine specialist referral, an emergency department visit or a change of general practitioner. Conversely, a single prescriber record may not show medicines supplied interstate, privately or through a hospital. The pharmacist should document the clinical explanation rather than treating an alert as proof of wrongdoing.

Include a patient conversation prompt. The pharmacist can check how the medicine is being taken, whether pain is improving, whether doses are being missed or repeated, and whether unwanted effects are occurring. Counsel on sedation, driving, alcohol, safe storage, disposal and the danger of sharing medicines. For patients at risk of opioid toxicity, discuss take-home naloxone and explain how family members or other support people can recognise an emergency and call Triple Zero (000).

Clear escalation criteria are essential. Contact the prescriber when the dose, timing, combination of medicines or patient history creates a material concern. Record the issue raised, the advice received, the agreed action and any follow-up date. If a prescription cannot be safely supplied, communicate calmly, protect confidentiality and explain the next step under pharmacy policy and relevant law.

Fit The Checklist Into Daily Workflow

A checklist will fail if it adds several minutes to every routine transaction without a clear trigger. Use a short front-page screen for all relevant prescriptions, followed by a more detailed assessment when a risk flag appears. Electronic dispensing software can display prompts, but the final tool should remain usable during outages, system downtime or a consultation away from the computer.

Create a consistent workflow from intake to follow-up. At intake, staff identify whether the prescription meets a trigger. During clinical review, the pharmacist completes the safety prompts and resolves discrepancies. At handover, the team records what has happened and what remains outstanding. When the patient returns, staff can see the previous plan without asking the same sensitive questions in front of others.

Privacy matters in Australian community pharmacies, where conversations may occur within hearing distance of the retail area. Offer a private consultation room for discussions about dependence, overdose, mental health or medicine-taking difficulties. A quiet and respectful interaction can improve the accuracy of the information collected and reduce the likelihood that a patient avoids future care.

Build downtime procedures into the design. Include a paper version or secure offline form, a process for later data entry and a named person responsible for reconciling records. The pharmacy should also specify how prescription images, clinical notes and monitoring information are stored, accessed and retained. Staff need to understand that a checklist is a health record and must be handled under privacy and professional obligations.

Training should use realistic scenarios rather than a single lecture. Practise a post-operative prescription with a short supply, a patient collecting methadone or buprenorphine, an early request after lost medicine and a patient taking an opioid with a benzodiazepine. Role-play can help staff use neutral language, respond to distress and escalate concerns without making accusations. A useful professional reflection may also draw on the value of careful observation found in early photojournalism: noticing small changes in behaviour or circumstance can be important, provided observations are recorded objectively rather than turned into assumptions.

Strengthen Communication And Care Coordination

Opioid stewardship works best when the pharmacy is connected to the wider care team. Establish a standard communication template for prescribers that states the relevant medicine, the specific concern, the patient’s reported use, the monitoring information reviewed and the proposed resolution. Secure messaging, telephone calls and documented fax processes may all be appropriate depending on local arrangements.

Avoid language that labels a person as “drug-seeking” without verified clinical evidence. Describe observable facts: an early request, a prescription from another clinic, an unexplained dose change or reported sedation. Ask the prescriber to clarify the treatment plan. This style supports a therapeutic relationship and produces a more defensible clinical record.

Care coordination is particularly important after hospital discharge. The patient may have received opioids in hospital, a short-term prescription from an emergency department and a regular medicine from a general practitioner. Confirm which medicine is current, what the intended duration is and whether a taper or review has been arranged. Where appropriate, encourage communication with the patient’s GP, pain specialist, addiction medicine service or opioid treatment provider.

Pharmacists should also know local referral pathways. These may include alcohol and other drug services, pain clinics, mental health services, Aboriginal Community Controlled Health Organisations and after-hours medical services. In regional Australia, travel distance and limited specialist access may affect the plan, so the checklist should prompt practical arrangements rather than assuming an immediate appointment is available.

Scope-of-practice developments make governance especially important. As pharmacist prescribing expands in selected Australian settings, every pharmacy should separate authorised prescribing activities from dispensing, supply and referral decisions. Policy discussions such as this contraception prescribing update illustrate why consent, role clarity, documentation and safeguards must develop alongside expanded responsibilities.

Audit Results And Improve The System

Choose a small set of measures that show whether the checklist is being used well. Possible indicators include the percentage of triggered prescriptions reviewed, documented prescriber interventions, naloxone discussions, identified medicine discrepancies, follow-up completion and incidents involving opioid-related harm. Avoid measuring staff solely by the number of refusals or alerts, as that can encourage defensive practice and undermine patient care.

Review a sample of completed checklists each month or quarter. Look for missing fields, repeated workflow barriers, unclear escalation instructions and evidence that patients were given useful counselling. Invite feedback from pharmacists, technicians and patients. A checklist that looks efficient in a meeting may be difficult to use during Saturday trading or when one pharmacist is managing a long queue.

Use incident reviews as learning exercises. Examine what information was available, which prompt was missed, whether the system was too complicated and whether communication with the prescriber was effective. Keep the discussion focused on processes and contributing conditions rather than blame. Update the checklist when legislation, monitoring platforms, medicine availability or professional guidance changes.

The document should remain short enough to use and detailed enough to guide action. Consider a one-page core checklist, supported by a procedure document containing escalation pathways, counselling points, privacy rules and contact details. Version control, review dates and an approved owner ensure that staff are working from the current tool.

A standardized opioid stewardship checklist becomes valuable when it supports thoughtful care at every stage: validating the prescription, understanding the patient’s circumstances, identifying preventable risk, coordinating with other clinicians and recording the reasoning behind a decision. Start with a small pilot in one pharmacy, review the experience with the team and refine the prompts before extending the process across multiple sites. Put the final version into daily practice, train every staff member who touches the workflow and audit its effect on safer opioid use.